EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Boosting Dendritic Cell Function in Cancer

Evangelos Giampazolias iD

Cancer Medicine · 2025

DOI: 10.1002/cam4.71062 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2025. Verfasst von Evangelos Giampazolias. Beteiligte Einrichtung: Cancer Immunosurveillance Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK. Hauptthemen laut MEDLINE: Dendritic Cells, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Society Research Grant, ERC Starting Grant, Cancer Research UK Institute Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Instruction of T cell immunity is a key function of sentinel leukocytes called dendritic cells (DC). Several studies in mice and humans have demonstrated a key role for DCs in promoting T cell responses to cancer and augmenting the efficacy of T cell‐based immunotherapies. Like other innate immune cells, DCs express a wide repertoire of receptors endowing them with the ability to detect microbial presence and tissue damage. These functions contribute to cancer immunity and have been previously linked to the induction of anti‐tumour CD8 + T cells and enhanced responses to immune checkpoint blockade (ICB) therapy. Here, I review some of the principles of DC biology, highlighting their functional characteristics that dictate T cell responses to cancer and how these can be harnessed in the design of novel immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsNeoplasmsHumansAnimalsImmunotherapyCD8-Positive T-LymphocytesImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

T cell primingactivationantigen presentationcancer immunitydendritic cellsimmunotherapy

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Cancer Immunosurveillance Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.

ORCID-Profile: Evangelos Giampazolias

Förderung

  • Royal Society Research Grant
  • ERC Starting Grant
  • Cancer Research UK Institute Award

Zitieren

APA

Giampazolias, E. (2025). Boosting Dendritic Cell Function in Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.71062

Vancouver

Giampazolias E. Boosting Dendritic Cell Function in Cancer. Cancer Medicine. 2025. doi:10.1002/cam4.71062

BibTeX
@article{Giampazolias2025,
  author = {Giampazolias, Evangelos},
  title = {Boosting Dendritic Cell Function in Cancer},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.71062}
}
Kostenlos starten →